Literature DB >> 29328406

miR-141 inhibits prostatic cancer cell proliferation and migration, and induces cell apoptosis via targeting of RUNX1.

Song Xu1, Jingping Ge1, Zhengyu Zhang1, Wenquan Zhou1.   

Abstract

Prostate cancer (PCa) is the most commonly diagnosed male malignancy and the second leading cause of male cancer-related deaths. miR-141 has been demonstrated to be inversely correlated with tumorigenicity. In the present study, we investigated the effect of miR-141 and runt-related transcription factor 1 (RUNX1) on PCa cells. We determined that miR-141 was expressed at a low level and RUNX1 was expressed at a high level in PCa tissues in comparison to that in adjacent normal tissues. Upregulation of miR-141 significantly inhibited cell growth, migration and invasion, and promoted cell apoptosis in PCa cells. Furthermore, miR-141 overexpression suppressed the expression of MMP-2 and MMP-9, and increased the expression of FOXO1 and p21. However, overexpression of RUNX1 could antagonize the effects of miR-141 on PCa cells. Our findings demonstrated that miR-141 could suppress cell growth, migration and invasion and induce cell apoptosis by targeting RUNX1 in PCa cells. Thus, miR-141/RUNX1 play critical roles in the progression of PCa and may be promising targets for the diagnosis and treatment of PCa.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29328406     DOI: 10.3892/or.2018.6209

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  11 in total

1.  The crucial role of DNA-dependent protein kinase and myelin transcription factor 1-like protein in the miR-141 tumor suppressor network.

Authors:  Bo Wang; Dongping Li; Youli Yao; Mieke Heyns; Anna Kovalchuk; Yaroslav Ilnytskyy; Rocio Rodriguez-Juarez; Roderick T Bronson; Gerlinde A S Metz; Olga Kovalchuk; Igor Kovalchuk
Journal:  Cell Cycle       Date:  2019-09-16       Impact factor: 4.534

2.  Validation of a serum 4-microRNA signature for the detection of lung cancer.

Authors:  Xia Yang; Wenmei Su; Xiuyuan Chen; Qianqian Geng; Jingyi Zhai; Hu Shan; Chunfang Guo; Zhuwen Wang; Han Fu; Hui Jiang; Jules Lin; Kiran Hari Lagisetty; Jie Zhang; Yali Li; Shuanying Yang; Pierre P Massion; David G Beer; Andrew C Chang; Nithya Ramnath; Guoan Chen
Journal:  Transl Lung Cancer Res       Date:  2019-10

Review 3.  MicroRNAs as Guardians of the Prostate: Those Who Stand before Cancer. What Do We Really Know about the Role of microRNAs in Prostate Biology?

Authors:  Thomas Andl; Kavya Ganapathy; Alexia Bossan; Ratna Chakrabarti
Journal:  Int J Mol Sci       Date:  2020-07-07       Impact factor: 5.923

4.  MicroRNA-141 suppresses growth and metastatic potential of head and neck squamous cell carcinoma.

Authors:  Zhiguo Zhao; Dan Gao; Tie Ma; Liping Zhang
Journal:  Aging (Albany NY)       Date:  2019-02-08       Impact factor: 5.682

Review 5.  Genetic and molecular biology of bladder cancer among Iranian patients.

Authors:  Majid Mojarrad; Meysam Moghbeli
Journal:  Mol Genet Genomic Med       Date:  2020-04-06       Impact factor: 2.183

6.  Endothelial progenitor cells-derived exosomal microRNA-21-5p alleviates sepsis-induced acute kidney injury by inhibiting RUNX1 expression.

Authors:  Yue Zhang; Hongdong Huang; Wenhu Liu; Sha Liu; Xue Yan Wang; Zong Li Diao; Ai Hua Zhang; Wang Guo; Xue Han; Xiaoqun Dong; Oleksandr Katilov
Journal:  Cell Death Dis       Date:  2021-03-30       Impact factor: 8.469

Review 7.  miRNA in Molecular Diagnostics.

Authors:  Maja Matulić; Paula Gršković; Andreja Petrović; Valerija Begić; Suzana Harabajsa; Petra Korać
Journal:  Bioengineering (Basel)       Date:  2022-09-09

8.  Down-regulated microRNA-141 facilitates osteoblast activity and inhibits osteoclast activity to ameliorate osteonecrosis of the femoral head via up-regulating TGF-β2.

Authors:  Lei Tian; Shui Sun; Wei Li; Lin Yuan; Xianquan Wang
Journal:  Cell Cycle       Date:  2020-02-23       Impact factor: 4.534

9.  MiR-93/miR-375: Diagnostic Potential, Aggressiveness Correlation and Common Target Genes in Prostate Cancer.

Authors:  Ewa Ciszkowicz; Paweł Porzycki; Małgorzata Semik; Ewa Kaznowska; Mirosław Tyrka
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

Review 10.  miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer.

Authors:  Noemi Arrighetti; Giovanni Luca Beretta
Journal:  Pharmaceutics       Date:  2021-03-13       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.